Work

Intermittent chemotherapy (CT) plus continuous or intermittent cetuximab (C) in the first-line treatment of advanced colorectal cancer (aCRC): Results of the two-arm phase II randomized MRC COIN-B trial.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.536

Authors: Harpreet Wasan, Richard A. Adams, Richard H. Wilson, Cheryl Pugh, David Fisher, Ayman Madi, Bruce Sizer, Rachel Butler, Angela M. Meade, Tim Maughan

Institutions: Queen's University Belfast, Hammersmith Hospital, University of Oxford, CRUK/MRC Oxford Institute for Radiation Oncology, Velindre Cancer Centre, Essex County Hospital, Medical Research Council

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591569412

Cites:

Cited by: 17

Related to: 10